Biotech Boom Fuels Parenteral Market

Colin MacKay, CEO of Symbiosis Pharmaceutical Services assesses the trends driving parenteral manufacturing in this guest blog as featured on Contract Pharma.“There are a number of factors that are influencing the growing demand for aseptically-processed parenteral products. The continued growth of the biotech sector and increased funding available are major drivers, while mergers and acquisitions within the contract manufacturing organization (CMO) space… Read More

It’s all change in Europe’s sterile manufacturing market… or is it?

The last six months has seen some major changes to the sterile manufacturing landscape here in Europe. There have been a number of exits and acquisitions that have no doubt made the market sit up and listen but has anything really changed?At an industry level, the demand for sterile injectable manufacturing capability is evident and industry publications regularly publish indicators of growth… Read More

Gauging Change in Europe’s Sterile Manufacturing Market

Colin MacKay, CEO of Symbiosis Pharmaceutical Services discusses ‘Gauging Change in Europe’s Sterile Manufacturing Market’ in this guest blog as featured on PharmTech.com.The past six months has seen some major changes to the sterile manufacturing landscape in Europe. There have been a number of exits and acquisitions that have no doubt grabbed headlines, but has anything really changed?At an industry level, the… Read More

Au revoir CPhI Paris

From the 7th until the 10th October the Symbiosis team attended CPhI, one of Europe’s largest pharmaceutical conferences held in Paris, France. Our two European Business Development Managers and our CEO were in attendance at the event with support from our friends at Scottish Development International. Thanks to those of you who visited our stand, especially given the challenges of navigating the… Read More

Symbiosis’ BIO 2014 Experience

For the Symbiosis team attending BIO 2014, the conference started in true BIO style with a spectacular welcome reception on the deck of the USS Midway Museum (below), involving great networking, good food, some lively entertainment, and a dash of maritime education. The evening came to an end as the San Diego bay shoreline was lit up by a BIO fireworks display… Read More

The Huge Potential of Antibody – Drug Conjugates

Symbiosis Pharmaceutical Services recently attended the World ADC conference in Frankfurt.  There, we were pleased to see 250 attendees from all over the world sharing ideas and reporting their experiences on the progress of ADC development. In combination with the event, World ADC published an insightful market research report  which is available for download by clicking the following link:-http://adcsummit-europe.com/uploads/ffiles/2014/01/659869.pdf.  This article illustrates… Read More

Insight into RABs Cabinets

RABS’ cabinets or Restricted Access Barrier Systems on a vertical Laminar Airflow cabinet are widely used in aseptic processing. These systems offer a flexible way of working over sanitised isolators and they negate the need for the use of sanitising agents such as hydrogen peroxide that may adverse impact the product or monitoring process. When working within a RABS, manual operations are… Read More

QP for GMP ASAP?

Recent reports in the media (http://www.in-pharmatechnologist.com/Regulatory-Safety/A-QP-for-GMP-That-is-the-suggestion-IRCA-launches-pharma-auditor-training) are suggesting that GMP auditors should have an equivalent professional qualification similar to that of a QP.  At Symbiosis, we asked our QA department what they think about this idea.  Murray McKay, QA director at Symbiosis with over 25 yrs experience said “This idea is not a new one.  I can see that a certain level… Read More

Get In Touch.


By ticking the box and clicking “Submit” below, you consent to receiving thought leadership, industry news, and invitations by email or other electronic means, which Symbiosis Pharmaceutical Services believes may be of value to you, relevant to your work and tailored to your professional profile and interests. This may include promotional information on products, services and events provided or organised by Symbiosis Pharmaceutical Services. By clicking the "Submit” button, you confirm that the information you have provided above is correct, and you agree to Symbiosis' processing of your personal data, including its transfer internationally and to third parties, in accordance with it's privacy policy.